Sotera Health Company

Fundamentals7.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • High operating margins
  • Strong free cashflow
  • Excessive leverage

AI
AI Summary

6.0

Sotera has transitioned from an operational-growth story to a liquidity-and-ownership trade—sponsor-led secondary supply and insider selling shorten the return timeline and make deleveraging and secondary absorption the primary drivers of near-term share performance. Actionable: treat SHC as a leveraged, event-sensitive services stock and closely monitor quarterly FCF/capex timing, net-leverage reductions, and any further sponsor share sales as the key catalysts that will validate or implode the current rich valuation.

FCF
SponsorSelling
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • High operating margins
  • Strong free cashflow
  • Excessive leverage

SHC combines industry-leading operating profitability and strong FCF/liquidity with high financial leverage, sizable intangibles and rich valuation multiples that constrain upside.

StrongMargins
HighLeverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Short-term downtrend
  • Support testing
  • Oversold bounce potential

SHC is in a clear short-term downtrend trading well below its last month SMA (~$15.01), testing $13.30–$13.50 support after falling from $17.49 to $13.50 and facing resistance at $15.70–$16.70, so a break below support is bearish while a move back above resistance would flip the bias.

bearish
watch
Support Level: $13.30–$13.50
Resistance Level: $15.70–$16.70

Rapid decline from $17.49 on 2026-02-20 to $13.50 on 2026-03-20 indicating sustained selling pressure

Sentiment & News

6.0

Key News Insights:

  • Revenue growth
  • Sponsor share sales
  • Board addition

Sotera reported modest revenue and EBITDA growth with 2026 guidance but faces near‑term pressure from a sponsor-led secondary share sale and active investor turnover.

operationalMomentum
sponsorSelloff

Fundamentals and guidance support steady upside, but the secondary offering and shareholder selling likely create short‑term stock pressure and valuation volatility